BioHarvest Sciences to Present at Noble Capital Markets Virtual Equity Conference on June 27, 2024
BioHarvest Sciences to Present at Noble Capital Markets Virtual Equity Conference on June 27, 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 24, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management will present at the Noble Capital Markets Virtual Equity Conference, being held June 26-27, 2024.
温哥华,英属哥伦比亚和以色列瑞霍沃特--(新闻稿公司-2024年6月24日) -BioHarvest Sciences公司(CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest"或"公司"),该公司开创其拥有专利的植物合成科技平台,今天宣布,管理层将在2024年6月26日至27日举行的Noble Capital Markets虚拟股权会议上发表演讲。
CEO Ilan Sobel is scheduled to host virtual one-on-one meetings with institutional investors throughout the event, and will host a virtual presentation as follows:
首席执行官伊兰·索贝尔将在活动期间预定与机构投资者进行虚拟一对一会议,并将按以下方式举行虚拟演示文稿:
Noble Capital Markets Virtual Equity Conference
Noble Capital Markets虚拟股权会议
Date: Thursday, June 27, 2024
Time: 1:30 p.m. Eastern time
Registration:
日期:2024年6月27日,星期四
时间:东部时间下午1:30
注册:
All interested media and investors are invited to register to attend the online presentation. Please join at least ten minutes before the start of the presentation to ensure timely participation.
欢迎所有感兴趣的媒体和投资者注册参加在线演示。请在演示开始前至少提前十分钟加入,以确保及时参加。
A video webcast of the presentation will be available following the event at BioHarvest.com and as part of a complete catalog of presentations available on ChannelChek, Noble's investor portal. The webcast will be archived on Channelchek.com for 90 days following the event. For more information or to schedule a meeting with management, please contact MZ Group at BHSC@mzgroup.us.
演示的视频网络直播将在BioHarvest.com上发布,并作为ChannelChek的完整演示目录的一部分提供,Noble的投资者门户网站。网络直播将在演示后的90天内在Channelchek.com上归档。有关更多信息或安排与管理层会面,请通过BHSC@mzgroup.us联系MZ Group。
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc.简介
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) (FSE: 8MV) is a leader in Botanical Synthesis, leveraging its patented technology process to grow the active ingredients in plants, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit .
BioHarvest Sciences Inc.(CSE:BHSC)(OTCQB:CNVCD)(FSE:8MV)是植物合成领域的领导者,利用其专利技术过程种植植物中的有效成分,而无需种植其植物底层。BioHarvest正在利用其植物合成技术来发展下一代基于科学和临床证明的治疗方案,在两个主要业务垂直领域中:作为代表客户寻求复杂分子的合同开发和生产组织(CDMO),以及作为专有营养保健产品的创造者,其中包括膳食补充剂。欲了解更多信息,请访问BioHarvest公司官网。
Forward-Looking Statements
前瞻性声明
Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
本新闻稿中的信息可能包含基于管理层的当前估计、信念、意图和期望而基于的前瞻性声明,且可能受到一系列风险和不确定性的影响,这可能导致实际结果与前瞻性声明中描述的结果有所不同。所有前瞻性声明本质上都是不确定的,实际结果可能会受到我们控制之外的一些实质性因素的影响。读者不应过度依赖前瞻性声明。BHSC无意通过常规管理讨论和分析披露之外的其他方式更新前瞻性声明披露。
Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.
加拿大证券交易所及其监管服务提供商不承担本发布内容的充分性或准确性的责任。
BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations & Director
(604) 622-1186
info@bioharvest.com
BioHarvest的公司联系方式:
Dave Ryan,投资者关系和董事副总裁
(604) 622-1186
info@bioharvest.com
Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
(949) 259-4987
BHSC@mzgroup.us
投资者关系联系人:
Lucas A. Zimmerman
董事总经理
MZ Group - MZ North America
(949) 259-4987
BHSC@mzgroup.us